Insider Transactions in Q3 2020 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
14,780
+40.0%
|
-
|
|
Sep 22
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
414,816
-43.89%
|
-
|
|
Sep 22
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
84,544
+50.0%
|
-
|
|
Sep 18
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
3,035
-0.58%
|
$261,010
$86.87 P/Share
|
|
Sep 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
8,965
-1.69%
|
$770,990
$86.98 P/Share
|
|
Sep 14
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
1,155
-0.22%
|
$97,020
$84.89 P/Share
|
|
Sep 10
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
22,845
-2.08%
|
$1,941,825
$85.47 P/Share
|
|
Sep 09
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
7,391
+50.0%
|
-
|
|
Sep 09
2020
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
207,408
-38.22%
|
-
|
|
Sep 09
2020
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
42,272
+50.0%
|
-
|
|
Sep 02
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.46%
|
$73,226
$94.15 P/Share
|
|
Sep 01
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-1.25%
|
$2,300,000
$92.44 P/Share
|
|
Sep 01
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.82%
|
$350,000
$14.22 P/Share
|
|
Sep 01
2020
|
Michael John Tomsicek Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-58.8%
|
$1,104,000
$92.27 P/Share
|
|
Sep 01
2020
|
Michael John Tomsicek Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+49.16%
|
$204,000
$17.75 P/Share
|
|
Sep 01
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
60,000
-67.85%
|
$5,520,000
$92.6 P/Share
|
|
Sep 01
2020
|
Bradley J Ph D Bolzon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
60,000
+31.67%
|
$1,680,000
$28.98 P/Share
|
|
Aug 19
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-3.71%
|
$2,500,000
$100.0 P/Share
|
|
Aug 19
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+3.58%
|
$350,000
$14.0 P/Share
|
|
Aug 13
2020
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Indirect |
14
+50.0%
|
-
|
|
Aug 13
2020
|
Ali Behbahani |
BUY
Other acquisition or disposition
|
Direct |
57
+18.21%
|
-
|
|
Aug 03
2020
|
Michael John Tomsicek Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-72.9%
|
$1,032,000
$86.79 P/Share
|
|
Aug 03
2020
|
Michael John Tomsicek Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+49.16%
|
$204,000
$17.75 P/Share
|
|
Jul 07
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-3.71%
|
$2,250,000
$90.0 P/Share
|
|
Jul 07
2020
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+1.83%
|
$175,000
$7.91 P/Share
|
|
Jul 06
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
20,000
-1.75%
|
$1,640,000
$82.58 P/Share
|
|
Jul 01
2020
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
50,000
-7.16%
|
$4,000,000
$80.0 P/Share
|